We are live on ! Find out more
MWM

Massachusetts Wealth Management Portfolio holdings

AUM $262M
1-Year Est. Return 48.07%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+48.07%
3 Year Est. Return
+106.31%
5 Year Est. Return
10 Year Est. Return
AUM
$162M
AUM Growth
+$3.38M
Cap. Flow
+$5.76M
Cap. Flow %
3.56%
Top 10 Hldgs %
28.82%
Holding
92
New
4
Increased
41
Reduced
32
Closed
2

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$226K
2
ALLE icon
Allegion
ALLE
+$221K
3
PFE icon
Pfizer
PFE
+$76.9K
4
NVO
Novo Nordisk
NVO
+$64.9K
5
UBS icon
UBS Group
UBS
+$63.4K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.77%
2 Industrials 18.13%
3 Financials 11.77%
4 Technology 10.46%
5 Consumer Staples 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEG icon
76
Public Service Enterprise Group
PEG
$37B
$431K 0.27%
5,100
-150
-3% -$13.3K
BIIB icon
77
Biogen
BIIB
$31.4B
$419K 0.26%
2,740
-135
-5% -$22.8K
FDX icon
78
FedEx
FDX
$74.3B
$374K 0.23%
1,330
DOW icon
79
Dow Inc
DOW
$21.4B
$374K 0.23%
9,316
-247
-3% -$11.5K
FCX icon
80
Freeport-McMoran
FCX
$110B
$337K 0.21%
8,842
-400
-4% -$17.9K
XOP icon
81
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.19B
$296K 0.18%
+2,235
New +$306K
UPS icon
82
United Parcel Service
UPS
$85.5B
$293K 0.18%
2,320
-25
-1% -$3.29K
IBB icon
83
iShares Biotechnology ETF
IBB
$10.5B
$270K 0.17%
+2,045
New +$287K
XLB icon
84
State Street Materials Select Sector SPDR ETF
XLB
$8.56B
$253K 0.16%
6,010
+630
+12% +$29.2K
AVGO icon
85
Broadcom
AVGO
$1.75T
$253K 0.16%
+1,090
New +$202K
V icon
86
Visa
V
$688B
$253K 0.16%
799
ORCL icon
87
Oracle
ORCL
$468B
$242K 0.15%
1,450
UNH icon
88
UnitedHealth
UNH
$360B
$231K 0.14%
457
NVO
89
Novo Nordisk
NVO
$200B
$219K 0.14%
2,550
-600
-19% -$64.9K
MS icon
90
Morgan Stanley
MS
$340B
$201K 0.12%
+1,602
New +$197K
ALLE icon
91
Allegion
ALLE
$13.3B
-1,519
Closed -$221K
AZN icon
92
AstraZeneca
AZN
$248B
-1,450
Closed -$226K

Similar funds

Massachusetts Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, Massachusetts Wealth Management held 92 positions worth $162M, up 2.1% from $159M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Massachusetts Wealth Management deployed $5.76M of net new capital in Q4 2024, opening 4 new positions and adding to 41 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 2,235 shares worth $296K.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $76.9K trimmed.

  • Massachusetts Wealth Management's largest Q4 2024 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 2,235 shares worth $296K.
  • Massachusetts Wealth Management added most to Baker Hughes in Q4 2024, an estimated $829K increase.
  • Massachusetts Wealth Management's biggest Q4 2024 reduction was Pfizer, cutting an estimated $76.9K.
  • Massachusetts Wealth Management fully exited AstraZeneca in Q4 2024, selling an estimated $226K.
  • Massachusetts Wealth Management's ten largest holdings make up 29% of its $162M portfolio in Q4 2024.
  • Massachusetts Wealth Management opened 4 new positions and closed 2 in Q4 2024.
  • Massachusetts Wealth Management's portfolio value rose 2.1% quarter-over-quarter to $162M.

Based on Massachusetts Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.